SB-215505 6-氯-5-甲基-N-(喹啉-5-基)二氢吲哚-1-甲酰胺
CAS 162100-15-4 MFCD05664741
化学结构图
SMILES: CC1=CC2CCN(C(=O)NC3=CC=CC4N=CC=CC=43)C=2C=C1Cl
化学属性
| Mol. Formula | C19H16N3OCl |
|---|---|
| Mol. Weight | 337.80 |
别名和识别编码
| Chemical Name | SB-215505 |
|---|---|
| Synonym | 6-Chloro-5-methyl-1-5-quinolycarbamoyl-indoline SB-215505 |
| MDL Number | MFCD05664741 |
| PubChem Substance ID | 24278573 |
| CAS Number | 162100-15-4 |
| Chemical Name Translation | 6-氯-5-甲基-N-(喹啉-5-基)二氢吲哚-1-甲酰胺 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Antagonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology,
- {SNA} Antagonists, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Diversification Ready Pharma-Developed Compounds, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, GlaxoSmithKline, Membrane Protein Biology Tools, Neuroscience, Neurotransmission, Neurotransmitters, S, Serotonergics, Serotonergics - Antagonists, 生化试剂, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学, 蛋白质及衍生物
相关文献及参考
- [2]. Sandor Kantor, et al. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. J Pharmacol. 2004 Aug;142(8):1332-42.
- [1]. C Reavill, et al. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br J Pharmacol. 1999 Feb;126(3):572-4.
- [1]. C Reavill, et al. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. Br J Pharmacol. 1999 Feb;126(3):572-4.
- [2]. Sandor Kantor, et al. Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505. J Pharmacol. 2004 Aug;142(8):1332-42.
